ERLEC1
Endoplasmic reticulum lectin 1
Also known as: C2orf30, CL25084, ERLEC_HUMAN, ERLECTIN, XTP3-B, XTP3TPB
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96DZ1
- Gene
- ERLEC1
- Ensembl
- ENSG00000068912
- Chromosome
- 2
- Canonical length
- 483 aa
- Protein class
- Predicted intracellular proteins, Transporters
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a resident endoplasmic reticulum (ER) protein that functions in N-glycan recognition. This protein is thought to be involved in ER-associated degradation via its interaction with the membrane-associated ubiquitin ligase complex. It also functions as a regulator of multiple cellular stress-response pathways in a manner that promotes metastatic cell survival. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 21. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
483 residues, UniProt reviewed canonical sequence.
>Q96DZ1|ERLEC1
1 MEEGGGGVRS LVPGGPVLLV LCGLLEASGG GRALPQLSDD IPFRVNWPGT EFSLPTTGVL
61 YKEDNYVIMT TAHKEKYKCI LPLVTSGDEE EEKDYKGPNP RELLEPLFKQ SSCSYRIESY
121 WTYEVCHGKH IRQYHEEKET GQKINIHEYY LGNMLAKNLL FEKEREAEEK EKSNEIPTKN
181 IEGQMTPYYP VGMGNGTPCS LKQNRPRSST VMYICHPESK HEILSVAEVT TCEYEVVILT
241 PLLCSHPKYR FRASPVNDIF CQSLPGSPFK PLTLRQLEQQ EEILRVPFRR NKEEDLQSTK
301 EERFPAIHKS IAIGSQPVLT VGTTHISKLT DDQLIKEFLS GSYCFRGGVG WWKYEFCYGK
361 HVHQYHEDKD SGKTSVVVGT WNQEEHIEWA KKNTARAYHL QDDGTQTVRM VSHFYGNGDI
421 CDITDKPRQV TVKLKCKESD SPHAVTVYML EPHSCQYILG VESPVICKIL DTADENGLLS
481 LPNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ERLEC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- epididymis: 85 nTPM
- prostate: 67 nTPM
- thyroid gland: 67 nTPM
- pancreas: 63 nTPM
- cervix: 62 nTPM
- parathyroid gland: 54 nTPM
Single-cell type
- plasma cells: 464 nCPM
- epididymal principal cells: 334 nCPM
- syncytiotrophoblasts: 243 nCPM
- late primary spermatocytes: 231 nCPM
- alveolar cells type 2: 210 nCPM
- corticotrophs: 191 nCPM
Immune cell
- basophil: 78 nTPM
- MAIT T-cell: 48 nTPM
- NK-cell: 46 nTPM
- plasmacytoid DC: 46 nTPM
- gdT-cell: 45 nTPM
- total PBMC: 44 nTPM
Brain region
- choroid plexus: 47 nTPM
- hypothalamus: 39 nTPM
- cerebral cortex: 37 nTPM
- midbrain: 31 nTPM
- pons: 30 nTPM
- thalamus: 29 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ERLEC1.
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 103 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mandibular prognathia
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.74
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.64
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- endoplasmic reticulum unfolded protein response
- ERAD pathway
- negative regulation of retrograde protein transport, ER to cytosol
- retrograde protein transport, ER to cytosol
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ERLEC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ERLEC1 as an antibody target. Whether an autoantibody or antibody against ERLEC1 could matter depends on whether native ERLEC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ERLEC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ERLEC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...